98%
921
2 minutes
20
This study presents a comprehensive theoretical analysis of PD-L1-In-1 (CHNO) using the B3LYP functional with the 6-311G(d) basis set, focusing on its structural, electronic, and spectroscopic properties. Fourier Transform Infrared (FT-IR), Raman, and UV-Vis spectra were simulated, and vibrational modes were assigned via potential energy distribution (PED) analysis using the VEDA 4 program. Natural Bond Orbital (NBO) analysis revealed hyperconjugative interactions (E) and provided insights into donor-acceptor electron densities. The energy band gap was obtained from HOMO-LUMO calculations and further analyzed through the density of states (DOS) spectrum. Electron Localization Function (ELF) and Localized Orbital Locator (LOL) analyses, performed using Multiwfn, highlighted regions of electron localization and orbital overlap. Reduced Density Gradient (RDG) analysis uncovered non-covalent interactions. Ground-state H and C NMR chemical shifts were predicted using the Gauge-Independent Atomic Orbital (GIAO) method. Fukui function analysis identified reactive sites and evaluated the chemical reactivity of the molecule. Molecular docking studies using AutoDock Vina explored interactions between PD-L1-In-1 and the PD-L1 checkpoint protein, shedding light on its potential biological activity. Notably, the simulations indicated strong ligand-protein interactions, positioning PD-L1-In-1 as a promising candidate for cancer immunotherapy targeting the PD-1/PD-L1 pathway.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12365063 | PMC |
http://dx.doi.org/10.1038/s41598-025-92180-9 | DOI Listing |
EMBO J
September 2025
Department of Infectious Diseases, Medical Research Institute, Zhongnan Hospital of Wuhan University; Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences; Wuhan University, Wuhan, 430071, China.
Inadequate antigen presentation by MHC-I in tumor microenvironment (TME) is a common immune escape mechanism. Here, we show that glycine decarboxylase (GLDC), a key enzyme in glycine metabolism, functions as an inhibitor of MHC-I expression in EGFR-activated tumor cells to induce immune escape by a mechanism independent of its enzymatic activity. Upon EGFR activation, GLDC is phosphorylated by SRC and subsequently translocated to the nucleus in human NSCLC cells.
View Article and Find Full Text PDFNat Rev Cancer
September 2025
Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Neurotoxicity is a common and potentially severe adverse effect from conventional and novel cancer therapy. The mechanisms that underlie clinical symptoms of central and peripheral nervous system injury remain incompletely understood. For conventional cytotoxic chemotherapy or radiotherapy, direct toxicities to brain structures and neurovascular damage may result in myelin degradation and impaired neurogenesis, which eventually translates into delayed neurodegeneration accompanied by cognitive symptoms.
View Article and Find Full Text PDFAnn Surg Oncol
September 2025
Department of Surgery, Divisions of Surgical Oncology, Colon and Rectal Surgery, Immunotherapy, University of Louisville School of Medicine, Louisville, KY, USA.
Nat Cell Biol
September 2025
NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
The colon exhibits higher propensity for tumour development than ileum. However, the role of immune microenvironment differences in driving this disparity remains unclear. Here, by comparing paired ileum and colon samples from patients with colorectal cancer (CRC) and healthy donors, we identified ileum-enriched CD160CD8 T cells with previously unrecognized characteristics, including resistance to terminal exhaustion and strong clonal expansion.
View Article and Find Full Text PDFNat Cell Biol
September 2025
Department of Oncology, University of Lausanne, Lausanne, Switzerland.